Vaxxas has received a manufacturing licence from Australia’s Therapeutic Goods Administration (TGA) for its high-density ...

Promising BioTech Vaxxas on Monday announced it will begin manufacturing its needle free vaccination patches in Brisbane for ...

Here we present a method for the fabrication of microarrays in which presynthesized oligonucleotides are ejected onto a glass surface by a Bubble Jet printing device. The oligonucleotides are then ...

Some of our most promising biotechs have taken part in a pre yuletide rush of clinical trial updates – and ... Read More The ...

Vaxxas Chair Sarah Meibusch said, “The TGA manufacturing licence marks a significant milestone for Vaxxas as we progress toward commercialising our HD-MAP technology. By reducing cold-chain ...

Australian biotech innovator Vaxxas has secured a major milestone in its journey to revolutionise vaccine delivery. The ...